Beatriz Val
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Colorectal Cancer Mortality Following an Organized Fecal Immunochemical Test-Based Screening Program.
Journal: JAMA network open
Published: August 05, 2026
Bile extracellular vesicles for early cholangiocarcinoma detection in primary sclerosing cholangitis.
Journal: JHEP reports : innovation in hepatology
Published: November 11, 2025
Statins halt polycystic liver disease by reprogramming metabolism and normalizing mitochondrial bioenergetics in cystic cholangiocytes.
Journal: Hepatology (Baltimore, Md.)
Published: July 15, 2025
Statins halt polycystic liver disease by reprogramming metabolism and normalizing mitochondrial bioenergetics in cystic cholangiocytes.
Journal: Hepatology (Baltimore, Md.)
Published: July 15, 2025
The Effect of Ursodeoxycholic Acid (UDCA) on Serum Expression of miR-34a and miR-506 in Patients with Chronic Cholestatic Liver Diseases.
Journal: Cells
Published: June 17, 2025
MARCO promotes cholangiocarcinogenesis by inducing immunosuppression and its targeting reduces tumor growth.
Journal: Signal transduction and targeted therapy
Published: December 12, 2024
New platinum derivatives selectively cause double-strand DNA breaks and death in naïve and cisplatin-resistant cholangiocarcinomas.
Journal: Journal of hepatology
Published: October 11, 2024
Targeting protein hyper-SUMOylation halts cholangiocarcinoma progression by impairing cancer cell viability and tumor-stroma cross talk.
Journal: Hepatology (Baltimore, Md.)
Published: September 12, 2024
Showing 1-8 of 8
Last Updated: 09/26/2026